182 related articles for article (PubMed ID: 15591144)
1. Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system.
Bayatti N; Hermann H; Lutz B; Behl C
Endocrinology; 2005 Mar; 146(3):1205-13. PubMed ID: 15591144
[TBL] [Abstract][Full Text] [Related]
2. Cyclic adenosine 3',5'-monophosphate responsive element binding protein phosphorylation is required but not sufficient for activation of corticotropin-releasing hormone transcription.
Liu Y; Kamitakahara A; Kim AJ; Aguilera G
Endocrinology; 2008 Jul; 149(7):3512-20. PubMed ID: 18372325
[TBL] [Abstract][Full Text] [Related]
3. Estrogen stimulates brain-derived neurotrophic factor expression in embryonic mouse midbrain neurons through a membrane-mediated and calcium-dependent mechanism.
Ivanova T; Küppers E; Engele J; Beyer C
J Neurosci Res; 2001 Oct; 66(2):221-30. PubMed ID: 11592117
[TBL] [Abstract][Full Text] [Related]
4. Low-level laser irradiation modulates brain-derived neurotrophic factor mRNA transcription through calcium-dependent activation of the ERK/CREB pathway.
Yan X; Liu J; Zhang Z; Li W; Sun S; Zhao J; Dong X; Qian J; Sun H
Lasers Med Sci; 2017 Jan; 32(1):169-180. PubMed ID: 27864646
[TBL] [Abstract][Full Text] [Related]
5. L-type channel inhibition by CB1 cannabinoid receptors is mediated by PTX-sensitive G proteins and cAMP/PKA in GT1-7 hypothalamic neurons.
Hoddah H; Marcantoni A; Comunanza V; Carabelli V; Carbone E
Cell Calcium; 2009; 46(5-6):303-12. PubMed ID: 19818494
[TBL] [Abstract][Full Text] [Related]
6. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
7. Characterization and genetic analysis of functional corticotropin-releasing hormone receptors in primary cerebellar cultures.
Barthel F; Loeffler JP
J Neurochem; 1993 Feb; 60(2):696-703. PubMed ID: 8380441
[TBL] [Abstract][Full Text] [Related]
8. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
[TBL] [Abstract][Full Text] [Related]
9. Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons.
Bayatti N; Zschocke J; Behl C
Endocrinology; 2003 Sep; 144(9):4051-60. PubMed ID: 12933679
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone (CRH) expression and protein kinase A mediated CRH receptor signalling in an immortalized hypothalamic cell line.
Kasckow J; Mulchahey JJ; Aguilera G; Pisarska M; Nikodemova M; Chen HC; Herman JP; Murphy EK; Liu Y; Rizvi TA; Dautzenberg FM; Sheriff S
J Neuroendocrinol; 2003 May; 15(5):521-9. PubMed ID: 12694378
[TBL] [Abstract][Full Text] [Related]
11. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
12. Excitatory actions of GABA increase BDNF expression via a MAPK-CREB-dependent mechanism--a positive feedback circuit in developing neurons.
Obrietan K; Gao XB; Van Den Pol AN
J Neurophysiol; 2002 Aug; 88(2):1005-15. PubMed ID: 12163549
[TBL] [Abstract][Full Text] [Related]
13. Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures.
Zhou J; Zhang H; Cohen RS; Pandey SC
Neuroendocrinology; 2005; 81(5):294-310. PubMed ID: 16179807
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells.
Yoshida T; Hashimoto K; Zimmer A; Maejima T; Araishi K; Kano M
J Neurosci; 2002 Mar; 22(5):1690-7. PubMed ID: 11880498
[TBL] [Abstract][Full Text] [Related]
15. Expression of functional CB1 cannabinoid receptors in retinoic acid-differentiated P19 embryonal carcinoma cells.
Svensson AC; Johansson M; Persson E; Carchenilla MS; Jacobsson SO
J Neurosci Res; 2006 May; 83(6):1128-40. PubMed ID: 16477621
[TBL] [Abstract][Full Text] [Related]
16. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
Hansson AC; Bermúdez-Silva FJ; Malinen H; Hyytiä P; Sanchez-Vera I; Rimondini R; Rodriguez de Fonseca F; Kunos G; Sommer WH; Heilig M
Neuropsychopharmacology; 2007 Jan; 32(1):117-26. PubMed ID: 16482090
[TBL] [Abstract][Full Text] [Related]
17. Neuromodulatory effect of Gαs- or Gαq-coupled G-protein-coupled receptor on NMDA receptor selectively activates the NMDA receptor/Ca2+/calcineurin/cAMP response element-binding protein-regulated transcriptional coactivator 1 pathway to effectively induce brain-derived neurotrophic factor expression in neurons.
Fukuchi M; Tabuchi A; Kuwana Y; Watanabe S; Inoue M; Takasaki I; Izumi H; Tanaka A; Inoue R; Mori H; Komatsu H; Takemori H; Okuno H; Bito H; Tsuda M
J Neurosci; 2015 Apr; 35(14):5606-24. PubMed ID: 25855176
[TBL] [Abstract][Full Text] [Related]
18. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
Derkinderen P; Valjent E; Toutant M; Corvol JC; Enslen H; Ledent C; Trzaskos J; Caboche J; Girault JA
J Neurosci; 2003 Mar; 23(6):2371-82. PubMed ID: 12657697
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.
Su SH; Wang YQ; Wu YF; Wang DP; Lin Q; Hai J
Behav Brain Res; 2016 Oct; 313():334-344. PubMed ID: 27424778
[TBL] [Abstract][Full Text] [Related]
20. Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3',5'-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopiomelanocortin promoter.
Mynard V; Latchoumanin O; Guignat L; Devin-Leclerc J; Bertagna X; Barré B; Fagart J; Coqueret O; Catelli MG
Mol Endocrinol; 2004 Dec; 18(12):2997-3010. PubMed ID: 15319449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
